These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5105727)

  • 21. Serotonergic involvement with neuroleptic catalepsy.
    Costall B; Fortune DH; Naylor RJ; Mardsen CD; Pycock C
    Neuropharmacology; 1975 Nov; 14(11):859-68. PubMed ID: 1239697
    [No Abstract]   [Full Text] [Related]  

  • 22. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?
    Janssen PA; Niemegeers CJ; Schellekens KH
    Arzneimittelforschung; 1966 Mar; 16(3):339-46. PubMed ID: 6013843
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of brain norepinephrine in neuroleptic-induced catalepsy in rats.
    Honma T; Fukushima H
    Pharmacol Biochem Behav; 1977 Dec; 7(6):501-6. PubMed ID: 201939
    [No Abstract]   [Full Text] [Related]  

  • 24. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 25. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of brain noradrenaline in morphine-induced stereotyped behaviour.
    Ayhan IH; Randrup A
    Psychopharmacologia; 1972; 27(3):203-12. PubMed ID: 4674514
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

  • 28. [Neuroleptics--phenothiazine and butyrophenone derivatives].
    Vetulani J
    Postepy Hig Med Dosw; 1969; 23(5):661-705. PubMed ID: 4908589
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Effect of oxypertine on anxiety-induced behaviour in baboons.
    Beattie IA; Berry PA; Lister RE
    Br J Pharmacol; 1972 Feb; 44(2):348P-349P. PubMed ID: 4203347
    [No Abstract]   [Full Text] [Related]  

  • 30. Oxypertine and primate behaviour.
    Berry PA; Lister RE; Beattie IA
    Postgrad Med J; 1972 Sep; 48(4):Suppl 4:11-4. PubMed ID: 4202023
    [No Abstract]   [Full Text] [Related]  

  • 31. The influence of anterior neostriatal lesions on the behavioural effects of spiroperidol in rats.
    Lowery SP; Barkley P; Baez LA
    Prog Neuropsychopharmacol; 1980; 4(3):269-76. PubMed ID: 7192004
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of brain dopamine in the antipsychotic effect of neuroleptics. Evidence from studies of amphetamine-neuroleptic interaction.
    Randrup A
    Mod Probl Pharmacopsychiatry; 1970; 5():60-5. PubMed ID: 5527170
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemical and pharmacological classification of neuroleptics.
    Janssen PA
    Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
    [No Abstract]   [Full Text] [Related]  

  • 34. Specific antagonism by dopamine inhibitors of items of amphetamine induced aggressive behaviour.
    Hasselager E; Rolinski Z; Randrup A
    Psychopharmacologia; 1972; 24(4):485-95. PubMed ID: 5064290
    [No Abstract]   [Full Text] [Related]  

  • 35. The activity of some neuroleptic drugs and amphetamine in normal and isolated rats.
    Kostowski W; Czlonkowski A
    Pharmacology; 1973; 10(2):82-7. PubMed ID: 4797045
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacology of the butyrophenones with special reference to methylperidol].
    Roos BE
    Nord Psykiatr Tidsskr; 1969; 23(1):3. PubMed ID: 5354544
    [No Abstract]   [Full Text] [Related]  

  • 37. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 38. Aminoalkylindoles: atypical dopamine antagonists.
    Costall B; Dannenburg WN; Johnson DN; Naylor RJ
    J Pharm Pharmacol; 1983 Apr; 35(4):229-33. PubMed ID: 6133932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats.
    Fog R; Pakkenberg H
    Exp Neurol; 1971 Apr; 31(1):75-86. PubMed ID: 5554976
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacologic and clinical properties of a new butyrophenone derivative (FR 33)].
    Kuhn R; Taeschler M; Schoch J
    Psychopharmacologia; 1966; 9(4):351-62. PubMed ID: 4871475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.